Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Xpress
“It’s not a case of cannabis being all good or all bad. It depends on how people are using it, what outcomes you’re looking at, what products are being used, for what reasons, and what part of the lifespan.” — Anika Guha, Ph.D., CU Anschutz
Psychiatry February 18th 2026
Medical News Today (MNT)
Even if menopause does lead to some gray matter loss, it won’t automatically lead to future cognitive decline or dementia.
Geriatrics February 11th 2026
Epilepsy Currents
By desynchronizing pathological rhythms, neuromodulation acts to induce plastic changes in thalamocortical circuits.
Neurology February 5th 2026
The chemical pattern in the brain suggests nutritional approaches—like appropriate choline supplementation—may help restore brain chemistry and improve outcomes for patients.
Family Medicine/General Practice November 18th 2025
MDLinx
For the first time, researchers found that empagliflozin, an established diabetes and heart medication, reduced markers of brain injury while restoring blood flow in critical brain regions.
Endocrinology, Diabetes, Metabolism November 3rd 2025
The findings stress the importance of diagnosis timing in neurodegenerative risk modeling and suggest that both early-life exposures and recent comorbidities contribute to disease vulnerability.
Endocrinology, Diabetes, Metabolism October 1st 2025